Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Singapore, Nov. 27, 2024 (GLOBE NEWSWIRE) -- SIMPPLE Ltd. (Nasdaq: SPPL, “SIMPPLE”, “the Company”), a leading technology provider and innovator in the integrated facilities management sector, today...
-
(Oslo, 26. november 2024) Fernando De Lapuerta trer inn i konsernledelsen i Statkraft som konserndirektør med ansvar for internasjonal virksomhet fra 1. januar 2025. De Lapuerta er i dag landsjef for...
-
Nedenfor følger informasjon om transaksjoner foretatt under fjerde transje av Equinor ASAs (OSE:EQNR, NYSE:EQNR, CEUX:EQNRO, TQEX:EQNRO) tilbakekjøpsprogram for 2024. Dato for når fjerde transje av...
-
Please see below information about transactions made under the fourth tranche of the 2024 share buy-back programme for Equinor ASA (OSE:EQNR, NYSE:EQNR, CEUX:EQNRO, TQEX:EQNRO). Date on which the...
-
MARBLEHEAD, Mass., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Today, the U.S. Department of Labor’s Occupational Safety and Health Administration (OSHA) released updated personal protective equipment (PPE)...
-
New York, Nov. 25, 2024 (GLOBE NEWSWIRE) -- PHI Group, Inc. (n/k/a Philux Global Group Inc., www.philuxglobal.com, PHIL), is pleased to announce that PHILUX GLOBAL ENERGY, INC. (“PGE”), a subsidiary...
-
Agreement will allow Inbank to extend PLN 701 million (EUR 163 million) in new financing Inbank to issue new loans to individuals in Poland for solar panels and heat pumps in the next three years...
-
22. november 2024Selskabsmeddelelse nr. 95/2024Til NASDAQ Copenhagen A/S Succession i Jyske RealkreditAdministrerende direktør Carsten Tirsbæk Madsen har efter 34 års...
-
Administrerende direktør Carsten Tirsbæk Madsen har efter 34 års ansættelse i Jyske Realkredit (tidligere BRFkredit) ønsket at gå på pension. Han fratræder i løbet af 2. kvartal 2025. Carsten Tirsbæk...
-
After three years of negotiation with the FDA, MAPS has successfully secured FDA clearance to conduct a clinical trial, MJP2, to examine the use of smoked cannabis for the treatment of PTSD symptoms...